Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Multicentre, Randomised, Comparative Study of the Efficacy and Safety of the Ultrasound Contrast Agents Sonazoid™ and SonoVue® in Subjects With Focal Liver Lesions Undergoing Pre- and Post-Contrast Ultrasound Imaging

NCT03335566 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT03335566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03335566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Multicentre, Randomised, Comparative Study of the Efficacy and Safety of the Ultrasound Contrast Agents Sonazoid™ and SonoVue® in Subjects With Focal Liver Lesions Undergoing Pre- and Post-Contrast Ultrasound Imaging
Lead sponsor
GE Healthcare
Phase
Phase 3
Overall status
Completed
Start date
May 11, 2014
Completion date
April 9, 2015
Enrollment
424 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

liver lesions